A detailed history of Victory Capital Management Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 68,998 shares of HRMY stock, worth $2.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,998
Previous 84,964 18.79%
Holding current value
$2.35 Million
Previous $2.56 Million 7.53%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$30.0 - $39.95 $478,980 - $637,841
-15,966 Reduced 18.79%
68,998 $2.76 Million
Q2 2024

Aug 05, 2024

BUY
$28.81 - $33.01 $858,998 - $984,226
29,816 Added 54.07%
84,964 $2.56 Million
Q1 2024

May 03, 2024

BUY
$29.93 - $35.06 $1.12 Million - $1.31 Million
37,368 Added 210.17%
55,148 $1.85 Million
Q4 2023

Feb 05, 2024

SELL
$19.2 - $33.78 $284,332 - $500,248
-14,809 Reduced 45.44%
17,780 $574,000
Q3 2023

Nov 06, 2023

BUY
$31.89 - $39.03 $114,963 - $140,703
3,605 Added 12.44%
32,589 $1.07 Million
Q2 2023

Jul 27, 2023

SELL
$30.5 - $37.4 $444,659 - $545,254
-14,579 Reduced 33.47%
28,984 $1.02 Million
Q1 2023

May 02, 2023

BUY
$30.8 - $53.92 $102,163 - $178,852
3,317 Added 8.24%
43,563 $1.42 Million
Q4 2022

Feb 10, 2023

BUY
$45.4 - $60.91 $104,647 - $140,397
2,305 Added 6.08%
40,246 $2.22 Million
Q4 2022

Feb 09, 2023

BUY
$45.4 - $60.91 $739,429 - $992,041
16,287 Added 75.21%
37,941 $2.09 Million
Q3 2022

Nov 02, 2022

SELL
$42.06 - $55.45 $5,846 - $7,707
-139 Reduced 0.64%
21,654 $959,000
Q2 2022

Aug 01, 2022

SELL
$33.54 - $52.15 $110,749 - $172,199
-3,302 Reduced 13.16%
21,793 $1.06 Million
Q1 2022

May 04, 2022

BUY
$33.14 - $51.13 $493,023 - $760,661
14,877 Added 145.6%
25,095 $1.13 Million
Q4 2021

Feb 07, 2022

BUY
$34.09 - $43.91 $348,331 - $448,672
10,218 New
10,218 $436,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.02B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.